Vanda Pharmaceuticals Inc.
VNDA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $278,534 | $242,148 | $417,253 | $871,550 |
| - Cash | $102,316 | $135,821 | $135,029 | $52,071 |
| + Debt | $12,360 | $9,404 | $11,141 | $12,366 |
| Enterprise Value | $188,578 | $115,731 | $293,365 | $831,845 |
| Revenue | $198,772 | $192,640 | $254,382 | $268,682 |
| % Growth | 3.2% | -24.3% | -5.3% | – |
| Gross Profit | $187,458 | $177,844 | $230,100 | $243,053 |
| % Margin | 94.3% | 92.3% | 90.5% | 90.5% |
| EBITDA | -$32,528 | -$10,942 | $9,062 | $45,006 |
| % Margin | -16.4% | -5.7% | 3.6% | 16.8% |
| Net Income | -$18,900 | $2,509 | $6,275 | $33,152 |
| % Margin | -9.5% | 1.3% | 2.5% | 12.3% |
| EPS Diluted | -0.32 | 0.044 | 0.11 | 0.58 |
| % Growth | -833.9% | -60.4% | -81% | – |
| Operating Cash Flow | -$15,757 | $12,801 | $31,984 | $64,214 |
| Capital Expenditures | -$490 | -$383 | -$679 | -$552 |
| Free Cash Flow | -$16,247 | $12,418 | $31,305 | $63,662 |